Medicare Beneficiaries: Confirm your type 2 diabetes diagnosis with your doctor Document inadequate blood sugar control despite other medications Have your doctor prescribe a GLP-1 medication approved for diabetes (Ozempic, Mounjaro, Trulicity, etc.) Your Part D plan should cover these medications, though prior authorization and step therapy may apply Medicaid Beneficiaries: Same diagnostic pathway applies Check your states specific formulary and prior authorization requirements Work with your doctor to submit comprehensive documentation Appeal denials with additional medical necessity evidence Strategy 2: Cardiovascular Risk Reduction For patients with established cardiovascular disease and obesity, the new cardiovascular indications may provide coverage: Eligibility Criteria: Documented cardiovascular disease (previous heart attack, stroke, peripheral artery disease, etc.) BMI of 27 or higher Age and risk factor considerations Documentation Needed: Cardiovascular disease diagnosis codes Recent cardiac testing or imaging Current cardiovascular medications Risk assessment documentation Your doctor must prescribe the medication specifically for cardiovascular risk reduction, with weight loss as a secondary benefit rather than the primary indication
Vi kh nng chng oxy ha mnh m, n bo v da khi cc tc nhn gy hi t mi trng nh nhim v nh nng mt tri, gip lm gim s xut hin ca cc du hiu lo ha nh np nhn v vt chn chim
Switching from Mounjaro (tirzepatide) to Wegovy (semaglutide) for weight loss is possible, but its something that should be guided by your healthcare provider
Surgical procedures are paid once, with long-lasting metabolic changes
In addition to the results from SURPASS 4, which was designed to provide preliminary evidence for the cardiovascular safety of tirzepatide, a separate analysis pooling all the clinical trials with tirzepatide was used to generate a pre-specified estimate of cardiovascular events [20] (Table 1)
If APAP levels exceed 10 mg/L or if AST/ALT are elevated, IV NAC should be initiated without delay to minimize liver damage [28]
